Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Shockwave Medical

Shockwave Medical

Shockwave Medical makes intravascular lithotripsy medical devices that help physicians treat calcified cardiovascular disease.

: Acquired, subsidiary of Johnson & Johnson
: 2009
: Santa Clara, CA, USUnited States

Shockwave Medical was founded on the idea that lithotripsy, a trusted technology used to break kidney stones, could be adapted into a catheter-based treatment that cracks calcified lesions in cardiovascular disease. Its business centers on the Shockwave IVL platform for coronary artery disease and peripheral artery disease, which uses sonic pressure waves to disrupt calcified plaque and restore blood flow.

Shockwave's competitive position rests on the first and only commercially available IVL platform for coronary artery disease and peripheral artery disease, differentiating its balloons from conventional angioplasty by adding lithotripsy sound waves that crack calcium lesions, often alongside stenting. It collaborates with physician partners, gathering real-world feedback on its current and future technologies.

M & A Snapshot

Johnson & Johnson
Acquired Shockwave Medical May 31, 2024 for $13.1B

Similar Companies

MiRus

GE Healthcare

Bausch & Lomb

Meril Life

Sartorius

Medpace

Insulet

Coloplast

Glaukos

Olympus

CooperCompanies

Solventum

Fresenius Medical Care

Smith & Nephew

Neuralink

Zydus Lifesciences

Biosplice Therapeutics

United Imaging

Penumbra

Baxter

Abbott India

FastWave Medical

Quick Facts

Who are Shockwave Medical's competitors?

Companies similar to Shockwave Medical include FastWave Medical, MiRus, GE Healthcare and Bausch & Lomb.

When was Shockwave Medical founded?

Shockwave Medical was founded in 2009.

Where is Shockwave Medical's headquarters located?

Shockwave Medical's headquarters is located in Santa Clara, CA, US.

How much disclosed funding has Shockwave Medical raised?

As of Apr 5, 2024, Shockwave Medical has disclosed funding of $148M (USD). Undisclosed round amounts are excluded.

Classification

Industry: Biotech
Medical Devices
Technology: Intravascular Lithotripsy
Geographic Exposure: Global

Model: Product Sales
Revenue: Product Sales
Customer: B2B

Tags: Medtech

Also Known As: Shockwave Medical, Inc.

Headquarters: 5403 Betsy Ross Drive
Santa Clara, CA, 95054
US